Literature DB >> 24529052

Initial human experience with Rubidium-82 renal PET/CT imaging.

Abdel K Tahari1, Paco E Bravo, Arman Rahmim, Frank M Bengel, Zsolt Szabo.   

Abstract

INTRODUCTION: Preclinical data have shown that Rubidium-82 chloride ((82)Rb) is a radiotracer with high first pass extraction and slow washout in the kidneys. The goal of this study was to investigate the feasibility of human kidney imaging with (82)Rb positron emission tomography (PET) and obtain quantitative data of its uptake non-invasively.
METHODS: Eight healthy volunteers underwent dynamic PET/CT imaging with (82)Rb. A preprogrammed pump was used to insure reproducible injections. Tissue time activity curves were generated from the renal cortex. An input function was derived from the left ventricular blood pool (LVBP), the descending thoracic aorta and the abdominal aorta. Renal blood flow was estimated by applying a two-compartment kinetic model. Results obtained with different input functions were compared.
RESULTS: Radiotracer accumulation was rapid and reached a plateau within 15-30 s after the bolus entered the kidneys. The derived K1 and k2 parameters were reproducible using input functions obtained from diverse vascular locations. K1 averaged 1.98 ± 0.14 mL/min/g. The average k2 was 0.35 ± 0.11/min. Correlation between K1 values obtained from the LVBP from different bed positions when the kidneys and abdominal aorta were in the same field of view was excellent (R = 0.95).
CONCLUSIONS: Non-invasive quantitative human kidney imaging with (82)Rb PET is feasible. Advantages of renal PET with (82)Rb include excellent image quality with high image resolution and contrast. (82)Rb has potential as a clinical renal imaging agent in humans.
© 2013 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  Rubidium-82 chloride; compartmental model; renal PET/CT; renal blood flow

Mesh:

Substances:

Year:  2013        PMID: 24529052     DOI: 10.1111/1754-9485.12079

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  6 in total

Review 1.  Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls.

Authors:  Arman Rahmim; Jinyi Qi; Vesna Sossi
Journal:  Med Phys       Date:  2013-06       Impact factor: 4.071

Review 2.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

3.  Renal Potassium Excretion Visualized on 82Rubidium PET/CT.

Authors:  Mads Ryø Jochumsen; Lars Poulsen Tolbod; Michael Borre; Jørgen Frøkiær; Kirsten Bouchelouche; Jens Sörensen
Journal:  Nucl Med Mol Imaging       Date:  2020-04-15

4.  Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects.

Authors:  Stine Sundgaard Langaa; Thomas Guldager Lauridsen; Frank Holden Mose; Claire Anne Fynbo; Jørn Theil; Jesper Nørgaard Bech
Journal:  EJNMMI Phys       Date:  2021-05-31

Review 5.  Advances in translational imaging of the microcirculation.

Authors:  Marie Guerraty; Akanksha Bhargava; Janaka Senarathna; Asher A Mendelson; Arvind P Pathak
Journal:  Microcirculation       Date:  2021-03-13       Impact factor: 2.679

6.  First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.

Authors:  David Kersting; Miriam Sraieb; Robert Seifert; Pedro Fragoso Costa; Sandra Kazek; Lukas Kessler; Lale Umutlu; Wolfgang Peter Fendler; Walter Jentzen; Ken Herrmann; Florian Büther; Michael Nader; Christoph Rischpler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-12       Impact factor: 10.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.